Reason for request
Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication “relief of broncho-obstructive symptoms in patients with chronic obstructive pulmonary disease”.
Clinical Benefit
| Substantial |
Le service médical rendu par FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé est important.
|
Clinical Added Value
| no clinical added value |
FORMOAIR 12 microgrammes/dose, solution pour inhalation en flacon pressurisé n'apporte pas d'amélioration du service médical rendu (ASMR V) par rapport aux autres bronchodilatateurs de longue durée d'action disponibles dans cette indication.
|
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
5a5QYXGepG6QGCmq
